We found that the global genomic N6medA in prefrontal cortex is positively correlated with human’s chronological age, and there is an increasing trend for N6medA levels in mild cognitive impairment and Alzheimer’s Disease.
1
—
—
We found that the global genomic N6medA in prefrontal cortex is positively correlated with human’s chronological age, and there is an increasing trend for N6medA levels in mild cognitive impairment and Alzheimer’s Disease.